Chengdu Easton Biopharmaceuticals Co Ltd
SSE:688513
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Chengdu Easton Biopharmaceuticals Co Ltd
SSE:688513
|
CN |
|
Sibanye Stillwater Ltd
F:47VS
|
ZA |
|
B
|
Brimstone Investment Corporation Ltd
JSE:BRT
|
ZA |
|
Duesenberg Technologies Inc
OTC:DUSYF
|
CA |
|
Serve Robotics Inc
NASDAQ:SERV
|
US |
|
Dyo Boya Fabrikalari Sanayi Ve Ticaret AS
IST:DYOBY.E
|
TR |
|
BNK Banking Corporation Ltd
ASX:BBC
|
AU |
|
K
|
Kung Sing Engineering Corp
TWSE:5521
|
TW |
|
Q
|
Qingdao Port International Co Ltd
HKEX:6198
|
CN |
Bankruptcy Probability
Chengdu Easton Biopharmaceuticals Co Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Chengdu Easton Biopharmaceuticals Co Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CN |
|
Chengdu Easton Biopharmaceuticals Co Ltd
SSE:688513
|
8.8B CNY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
650.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
362.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
OTC:RHHBF
|
354B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
220.7B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
194.8B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
288.8B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.2T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
157.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
128.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Chengdu Easton Biopharmaceuticals Co Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Chengdu Easton Biopharmaceuticals Co Ltd has total debt of 145.9m CNY. This includes both short-term (116.6m CNY) and long-term (29.3m CNY) debt.
You can find a full breakdown on its Balance Sheet.